Cerebrospinal Fluid From Alzheimer’s Disease Patients as an Optimal Formulation for Therapeutic Application of Mesenchymal Stem Cells in Alzheimer’s Disease
Scientific Reports - United Kingdom
doi 10.1038/s41598-018-37252-9
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 24, 2019
Authors
Publisher
Springer Science and Business Media LLC